BREAKING NEWS
Press Release July 12, 2010
AntiCancer, Inc. and Cambridge Research & Instrumentation
Settle Patent Litigation after 3 ˝ Years
AntiCancer, Inc., and Cambridge Research & Instrumentation, Inc. (CRi) have agreed to settle patent litigation which has been ongoing between the two companies in the U.S. District Court for the Southern District of California since January 2007. Company presidents Robert M. Hoffman, Ph.D. (of AntiCancer) and George A. Abe (of CRi) announced the agreement today. The settlement resolves all claims between the parties. Financial terms were not disclosed.
AntiCancer, Inc. is a leader in providing animal models, cell lines, and
therapeutics for imaging tumor cells in small animals. Its stock is privately
held. AntiCancer is headquartered in San Diego, California, where it remains the
oldest free-standing biotechnology company in the San Diego cluster. AntiCancer
has subsidiaries in China, Japan, and Korea. More information about AntiCancer
is available at www.anticancer.com. CRi develops and sells optical imaging
systems to advance biomedical research and molecular-based drug and diagnostic
development. Its stock is privately held. CRi is headquartered in Woburn,
Massachusetts. More information about CRi is available at www.cri-inc.com.
New Gene-Based Fluorescence-Labeling Technology for Cancer Surgery
Kishimoto, H., Zhao, M., Hayashi, K., Urata,
Y., Tanaka, N., Fujiwara, T., Penman, S., and Hoffman, R.M. In vivo internal
tumor illumination by telomerase-dependent adenoviral GFP for precise
surgical navigation. Proc. Natl. Acad. Sci. USA, 1-6, 14514-14517, 2009
![]()
Human hair follicle stem cells repair nerves
Amoh, Y., Kanoh, M., Niiyama, S.,
Hamada, Y., Kawahara, K., Sato, Y., Hoffman, R.M., and Katsuoka, K. Human
hair follicle pluripotent stem (hfPS) cells promote regeneration of
peripheral-nerve injury: An advantageous alternative to ES and iPS cells. J.
Cell. Biochem. 107, 1016-1020, 2009
![]()
Scientists extract pluripotent stem
cells for medical use from and unexpected source: hair:
![]()
National Cancer Institute (NCI) designates AntiCancer Inc. as a Success Story
![]()
Hair follicle stem cells used to repair spinal cord injury
Amoh,
Y., Li, L., Katsuoka, K., and Hoffman, R.M. Multipotent
hair follicle stem cells promote repair of spinal cord injury and recovery of
walking function. Cell Cycle 7,
1865-1869, 2008.
Kevin Hrusovsky, President and CEO of Caliper, and Robert Hoffman, Ph.D., President and CEO of AntiCancer